Global POC Diagnostics Market Growth 2024-2030
POC Diagnostics, with a market size of $25.11 billion in 2023, is anticipated to reach $48.17 billion by 2030, driven by rising demand in downstream markets and a 9.8% CAGR.
- Bonafide Trust
- 04-01-2024
- Pages : 128
- Figures : 91
- Tables : 180
- Region : Global
- Category : Lifescience
- Medical Devices
Traditionally, diagnosing illnesses involved a trip to a doctor's office or clinic. Patients would provide a blood, urine, or tissue sample, which would then be sent to a laboratory for analysis. This process often resulted in frustrating delays of hours or even days. Patients were left waiting anxiously for results, unsure of their condition and unable to begin treatment. The global Point-of-Care (POC) diagnostics market is transforming healthcare by offering rapid and convenient testing right at the point of care - a doctor's office, clinic, or even at home. POC tests eliminate the need for sending samples to an off-site lab, delivering test results in a matter of minutes. This expedited turnaround time allows healthcare professionals to make quicker diagnoses and treatment decisions, potentially improving patient outcomes. For example, a rapid strep test can confirm a strep throat infection during a doctor's visit, eliminating unnecessary antibiotics and ensuring the patient receives the most appropriate treatment right away. Additionally, POC tests can improve patient satisfaction by reducing anxiety and frustration associated with waiting for lab results. According to our publisher’s latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period.
What's Inside a Bonafide Research`s industry report?
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleThe research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of POC Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the POC Diagnostics market. Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made. In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%. In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.
Key Features: The report on POC Diagnostics market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the POC Diagnostics market. It may include historical data, market segmentation by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the POC Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Market Drivers: • Rising Burden of Chronic Disease: The growing prevalence of conditions like diabetes and heart disease necessitates regular monitoring, making POC tests ideal for both patients and healthcare providers. • Aging Population: An expanding elderly population with age-related health concerns fuels demand for convenient and accessible diagnostic solutions. Market Trends: • Tech Revolution: Advancements in microfluidics and biosensors are leading to the creation of more sophisticated, user-friendly, and accurate POC tests. • Decentralized Healthcare Shift: The growing trend towards delivering care outside of traditional hospitals creates a need for readily available diagnostic tools, making POC tests highly valuable. Market Challenges: • Cost Considerations: High upfront costs for POC devices and test cartridges can limit their widespread adoption in certain settings. • Regulatory Hurdles: Stringent regulatory requirements for new POC tests can hinder market entry for innovative products. Competitive Landscape: The research report provides analysis of the competitive landscape within the POC Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the POC Diagnostics industry. This include advancements in POC Diagnostics technology, POC Diagnostics new entrants, POC Diagnostics new investment, and other innovations that are shaping the future of POC Diagnostics. • Microfluidics Miniaturization: Shrinking test components onto microfluidic chips allows for compact, portable POC devices. • Biosensor Innovation: Advanced biosensors are being developed to detect even the tiniest biological markers for faster and more accurate diagnoses. • Connectivity on the Rise: Integration with smartphones and telemedicine platforms allows for real-time data transmission and remote consultations, enhancing care coordination. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the POC Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for POC Diagnostics product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the POC Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting POC Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the POC Diagnostics market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the POC Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. • Tech Revolution: Advancements in microfluidics and biosensors will lead to even more accurate, miniaturized, and user-friendly POC tests. • AI Integration: Expect AI-powered POC tests that can analyze results and suggest treatment options, aiding healthcare professionals. • Remote Patient Monitoring: POC tests will be seamlessly integrated with telehealth platforms, enabling remote monitoring of chronic conditions. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the POC Diagnostics market. • Chronic Care Management: Develop POC tests for diabetes, heart disease, and other chronic conditions, empowering patients for self-care and improving clinical decision-making. • Decentralized Diagnostics Hero: Address the rise of home-based and remote care with user-friendly POC tests for various health concerns. • Emerging Market Access: Make POC diagnostics more affordable in developing regions with limited lab infrastructure, expanding healthcare reach. Market Segmentation: POC Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Segmentation by type Blood Glucose Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Pregnancy and Fertility Testing Blood Gas or Electrolytes Testing Tumor Markers Testing Urinalysis Testing Cholesterol Testing Others Segmentation by application Clinics Hospitals Laboratory Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Alere Roche Abbott Laboratories Johnson & Johnson Siemens Healthcare Danaher Bayer Healthcare Beckman Coulter Nipro Diagnostics Bio-Rad Laboratories Nova Biomedical BioMerieux Quidel Helena Laboratories OraSure Technologies Accriva Abaxis Chembio Diagnostics Trinity Biotech
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global POC Diagnostics Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for POC Diagnostics by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for POC Diagnostics by Country/Region, 2019, 2023 & 2030
- 2.2 POC Diagnostics Segment by Type
- 2.2.1 Blood Glucose Testing
- 2.2.2 Infectious Diseases Testing
- 2.2.3 Cardiac Markers Testing
- 2.2.4 Coagulation Testing
- 2.2.5 Pregnancy and Fertility Testing
- 2.2.6 Blood Gas or Electrolytes Testing
- 2.2.7 Tumor Markers Testing
- 2.2.8 Urinalysis Testing
- 2.2.9 Cholesterol Testing
- 2.2.10 Others
- 2.3 POC Diagnostics Sales by Type
- 2.3.1 Global POC Diagnostics Sales Market Share by Type (2019-2024)
- 2.3.2 Global POC Diagnostics Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global POC Diagnostics Sale Price by Type (2019-2024)
- 2.4 POC Diagnostics Segment by Application
- 2.4.1 Clinics
- 2.4.2 Hospitals
- 2.4.3 Laboratory
- 2.4.4 Others
- 2.5 POC Diagnostics Sales by Application
- 2.5.1 Global POC Diagnostics Sale Market Share by Application (2019-2024)
- 2.5.2 Global POC Diagnostics Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global POC Diagnostics Sale Price by Application (2019-2024)
- 3 Global POC Diagnostics by Company
- 3.1 Global POC Diagnostics Breakdown Data by Company
- 3.1.1 Global POC Diagnostics Annual Sales by Company (2019-2024)
- 3.1.2 Global POC Diagnostics Sales Market Share by Company (2019-2024)
- 3.2 Global POC Diagnostics Annual Revenue by Company (2019-2024)
- 3.2.1 Global POC Diagnostics Revenue by Company (2019-2024)
- 3.2.2 Global POC Diagnostics Revenue Market Share by Company (2019-2024)
- 3.3 Global POC Diagnostics Sale Price by Company
- 3.4 Key Manufacturers POC Diagnostics Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers POC Diagnostics Product Location Distribution
- 3.4.2 Players POC Diagnostics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for POC Diagnostics by Geographic Region
- 4.1 World Historic POC Diagnostics Market Size by Geographic Region (2019-2024)
- 4.1.1 Global POC Diagnostics Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global POC Diagnostics Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic POC Diagnostics Market Size by Country/Region (2019-2024)
- 4.2.1 Global POC Diagnostics Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global POC Diagnostics Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas POC Diagnostics Sales Growth
- 4.4 APAC POC Diagnostics Sales Growth
- 4.5 Europe POC Diagnostics Sales Growth
- 4.6 Middle East & Africa POC Diagnostics Sales Growth
- 5 Americas
- 5.1 Americas POC Diagnostics Sales by Country
- 5.1.1 Americas POC Diagnostics Sales by Country (2019-2024)
- 5.1.2 Americas POC Diagnostics Revenue by Country (2019-2024)
- 5.2 Americas POC Diagnostics Sales by Type
- 5.3 Americas POC Diagnostics Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC POC Diagnostics Sales by Region
- 6.1.1 APAC POC Diagnostics Sales by Region (2019-2024)
- 6.1.2 APAC POC Diagnostics Revenue by Region (2019-2024)
- 6.2 APAC POC Diagnostics Sales by Type
- 6.3 APAC POC Diagnostics Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe POC Diagnostics by Country
- 7.1.1 Europe POC Diagnostics Sales by Country (2019-2024)
- 7.1.2 Europe POC Diagnostics Revenue by Country (2019-2024)
- 7.2 Europe POC Diagnostics Sales by Type
- 7.3 Europe POC Diagnostics Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa POC Diagnostics by Country
- 8.1.1 Middle East & Africa POC Diagnostics Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa POC Diagnostics Revenue by Country (2019-2024)
- 8.2 Middle East & Africa POC Diagnostics Sales by Type
- 8.3 Middle East & Africa POC Diagnostics Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of POC Diagnostics
- 10.3 Manufacturing Process Analysis of POC Diagnostics
- 10.4 Industry Chain Structure of POC Diagnostics
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 POC Diagnostics Distributors
- 11.3 POC Diagnostics Customer
- 12 World Forecast Review for POC Diagnostics by Geographic Region
- 12.1 Global POC Diagnostics Market Size Forecast by Region
- 12.1.1 Global POC Diagnostics Forecast by Region (2025-2030)
- 12.1.2 Global POC Diagnostics Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global POC Diagnostics Forecast by Type
- 12.7 Global POC Diagnostics Forecast by Application
- 13 Key Players Analysis
- 13.1 Alere
- 13.1.1 Alere Company Information
- 13.1.2 Alere POC Diagnostics Product Portfolios and Specifications
- 13.1.3 Alere POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Alere Main Business Overview
- 13.1.5 Alere Latest Developments
- 13.2 Roche
- 13.2.1 Roche Company Information
- 13.2.2 Roche POC Diagnostics Product Portfolios and Specifications
- 13.2.3 Roche POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Roche Main Business Overview
- 13.2.5 Roche Latest Developments
- 13.3 Abbott Laboratories
- 13.3.1 Abbott Laboratories Company Information
- 13.3.2 Abbott Laboratories POC Diagnostics Product Portfolios and Specifications
- 13.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Abbott Laboratories Main Business Overview
- 13.3.5 Abbott Laboratories Latest Developments
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Company Information
- 13.4.2 Johnson & Johnson POC Diagnostics Product Portfolios and Specifications
- 13.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Johnson & Johnson Main Business Overview
- 13.4.5 Johnson & Johnson Latest Developments
- 13.5 Siemens Healthcare
- 13.5.1 Siemens Healthcare Company Information
- 13.5.2 Siemens Healthcare POC Diagnostics Product Portfolios and Specifications
- 13.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Siemens Healthcare Main Business Overview
- 13.5.5 Siemens Healthcare Latest Developments
- 13.6 Danaher
- 13.6.1 Danaher Company Information
- 13.6.2 Danaher POC Diagnostics Product Portfolios and Specifications
- 13.6.3 Danaher POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Danaher Main Business Overview
- 13.6.5 Danaher Latest Developments
- 13.7 Bayer Healthcare
- 13.7.1 Bayer Healthcare Company Information
- 13.7.2 Bayer Healthcare POC Diagnostics Product Portfolios and Specifications
- 13.7.3 Bayer Healthcare POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Bayer Healthcare Main Business Overview
- 13.7.5 Bayer Healthcare Latest Developments
- 13.8 Beckman Coulter
- 13.8.1 Beckman Coulter Company Information
- 13.8.2 Beckman Coulter POC Diagnostics Product Portfolios and Specifications
- 13.8.3 Beckman Coulter POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Beckman Coulter Main Business Overview
- 13.8.5 Beckman Coulter Latest Developments
- 13.9 Nipro Diagnostics
- 13.9.1 Nipro Diagnostics Company Information
- 13.9.2 Nipro Diagnostics POC Diagnostics Product Portfolios and Specifications
- 13.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Nipro Diagnostics Main Business Overview
- 13.9.5 Nipro Diagnostics Latest Developments
- 13.10 Bio-Rad Laboratories
- 13.10.1 Bio-Rad Laboratories Company Information
- 13.10.2 Bio-Rad Laboratories POC Diagnostics Product Portfolios and Specifications
- 13.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Bio-Rad Laboratories Main Business Overview
- 13.10.5 Bio-Rad Laboratories Latest Developments
- 13.11 Nova Biomedical
- 13.11.1 Nova Biomedical Company Information
- 13.11.2 Nova Biomedical POC Diagnostics Product Portfolios and Specifications
- 13.11.3 Nova Biomedical POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Nova Biomedical Main Business Overview
- 13.11.5 Nova Biomedical Latest Developments
- 13.12 BioMerieux
- 13.12.1 BioMerieux Company Information
- 13.12.2 BioMerieux POC Diagnostics Product Portfolios and Specifications
- 13.12.3 BioMerieux POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 BioMerieux Main Business Overview
- 13.12.5 BioMerieux Latest Developments
- 13.13 Quidel
- 13.13.1 Quidel Company Information
- 13.13.2 Quidel POC Diagnostics Product Portfolios and Specifications
- 13.13.3 Quidel POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Quidel Main Business Overview
- 13.13.5 Quidel Latest Developments
- 13.14 Helena Laboratories
- 13.14.1 Helena Laboratories Company Information
- 13.14.2 Helena Laboratories POC Diagnostics Product Portfolios and Specifications
- 13.14.3 Helena Laboratories POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Helena Laboratories Main Business Overview
- 13.14.5 Helena Laboratories Latest Developments
- 13.15 OraSure Technologies
- 13.15.1 OraSure Technologies Company Information
- 13.15.2 OraSure Technologies POC Diagnostics Product Portfolios and Specifications
- 13.15.3 OraSure Technologies POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 OraSure Technologies Main Business Overview
- 13.15.5 OraSure Technologies Latest Developments
- 13.16 Accriva
- 13.16.1 Accriva Company Information
- 13.16.2 Accriva POC Diagnostics Product Portfolios and Specifications
- 13.16.3 Accriva POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.16.4 Accriva Main Business Overview
- 13.16.5 Accriva Latest Developments
- 13.17 Abaxis
- 13.17.1 Abaxis Company Information
- 13.17.2 Abaxis POC Diagnostics Product Portfolios and Specifications
- 13.17.3 Abaxis POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.17.4 Abaxis Main Business Overview
- 13.17.5 Abaxis Latest Developments
- 13.18 Chembio Diagnostics
- 13.18.1 Chembio Diagnostics Company Information
- 13.18.2 Chembio Diagnostics POC Diagnostics Product Portfolios and Specifications
- 13.18.3 Chembio Diagnostics POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.18.4 Chembio Diagnostics Main Business Overview
- 13.18.5 Chembio Diagnostics Latest Developments
- 13.19 Trinity Biotech
- 13.19.1 Trinity Biotech Company Information
- 13.19.2 Trinity Biotech POC Diagnostics Product Portfolios and Specifications
- 13.19.3 Trinity Biotech POC Diagnostics Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.19.4 Trinity Biotech Main Business Overview
- 13.19.5 Trinity Biotech Latest Developments
- 14 Research Findings and Conclusion
Table 1. POC Diagnostics Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. POC Diagnostics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Blood Glucose Testing
Table 4. Major Players of Infectious Diseases Testing
Table 5. Major Players of Cardiac Markers Testing
Table 6. Major Players of Coagulation Testing
Table 7. Major Players of Pregnancy and Fertility Testing
Table 8. Major Players of Blood Gas or Electrolytes Testing
Table 9. Major Players of Tumor Markers Testing
Table 10. Major Players of Urinalysis Testing
Table 11. Major Players of Cholesterol Testing
Table 12. Major Players of Others
Table 13. Global POC Diagnostics Sales by Type (2019-2024) & (K Units)
Table 14. Global POC Diagnostics Sales Market Share by Type (2019-2024)
Table 15. Global POC Diagnostics Revenue by Type (2019-2024) & ($ million)
Table 16. Global POC Diagnostics Revenue Market Share by Type (2019-2024)
Table 17. Global POC Diagnostics Sale Price by Type (2019-2024) & (USD/Unit)
Table 18. Global POC Diagnostics Sales by Application (2019-2024) & (K Units)
Table 19. Global POC Diagnostics Sales Market Share by Application (2019-2024)
Table 20. Global POC Diagnostics Revenue by Application (2019-2024)
Table 21. Global POC Diagnostics Revenue Market Share by Application (2019-2024)
Table 22. Global POC Diagnostics Sale Price by Application (2019-2024) & (USD/Unit)
Table 23. Global POC Diagnostics Sales by Company (2019-2024) & (K Units)
Table 24. Global POC Diagnostics Sales Market Share by Company (2019-2024)
Table 25. Global POC Diagnostics Revenue by Company (2019-2024) ($ Millions)
Table 26. Global POC Diagnostics Revenue Market Share by Company (2019-2024)
Table 27. Global POC Diagnostics Sale Price by Company (2019-2024) & (USD/Unit)
Table 28. Key Manufacturers POC Diagnostics Producing Area Distribution and Sales Area
Table 29. Players POC Diagnostics Products Offered
Table 30. POC Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global POC Diagnostics Sales by Geographic Region (2019-2024) & (K Units)
Table 34. Global POC Diagnostics Sales Market Share Geographic Region (2019-2024)
Table 35. Global POC Diagnostics Revenue by Geographic Region (2019-2024) & ($ millions)
Table 36. Global POC Diagnostics Revenue Market Share by Geographic Region (2019-2024)
Table 37. Global POC Diagnostics Sales by Country/Region (2019-2024) & (K Units)
Table 38. Global POC Diagnostics Sales Market Share by Country/Region (2019-2024)
Table 39. Global POC Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 40. Global POC Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 41. Americas POC Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Americas POC Diagnostics Sales Market Share by Country (2019-2024)
Table 43. Americas POC Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 44. Americas POC Diagnostics Revenue Market Share by Country (2019-2024)
Table 45. Americas POC Diagnostics Sales by Type (2019-2024) & (K Units)
Table 46. Americas POC Diagnostics Sales by Application (2019-2024) & (K Units)
Table 47. APAC POC Diagnostics Sales by Region (2019-2024) & (K Units)
Table 48. APAC POC Diagnostics Sales Market Share by Region (2019-2024)
Table 49. APAC POC Diagnostics Revenue by Region (2019-2024) & ($ Millions)
Table 50. APAC POC Diagnostics Revenue Market Share by Region (2019-2024)
Table 51. APAC POC Diagnostics Sales by Type (2019-2024) & (K Units)
Table 52. APAC POC Diagnostics Sales by Application (2019-2024) & (K Units)
Table 53. Europe POC Diagnostics Sales by Country (2019-2024) & (K Units)
Table 54. Europe POC Diagnostics Sales Market Share by Country (2019-2024)
Table 55. Europe POC Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 56. Europe POC Diagnostics Revenue Market Share by Country (2019-2024)
Table 57. Europe POC Diagnostics Sales by Type (2019-2024) & (K Units)
Table 58. Europe POC Diagnostics Sales by Application (2019-2024) & (K Units)
Table 59. Middle East & Africa POC Diagnostics Sales by Country (2019-2024) & (K Units)
Table 60. Middle East & Africa POC Diagnostics Sales Market Share by Country (2019-2024)
Table 61. Middle East & Africa POC Diagnostics Revenue by Country (2019-2024) & ($ Millions)
Table 62. Middle East & Africa POC Diagnostics Revenue Market Share by Country (2019-2024)
Table 63. Middle East & Africa POC Diagnostics Sales by Type (2019-2024) & (K Units)
Table 64. Middle East & Africa POC Diagnostics Sales by Application (2019-2024) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of POC Diagnostics
Table 66. Key Market Challenges & Risks of POC Diagnostics
Table 67. Key Industry Trends of POC Diagnostics
Table 68. POC Diagnostics Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. POC Diagnostics Distributors List
Table 71. POC Diagnostics Customer List
Table 72. Global POC Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 73. Global POC Diagnostics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Americas POC Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Americas POC Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. APAC POC Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 77. APAC POC Diagnostics Revenue Forecast by Region (2025-2030) & ($ millions)
Table 78. Europe POC Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 79. Europe POC Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 80. Middle East & Africa POC Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 81. Middle East & Africa POC Diagnostics Revenue Forecast by Country (2025-2030) & ($ millions)
Table 82. Global POC Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 83. Global POC Diagnostics Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 84. Global POC Diagnostics Sales Forecast by Application (2025-2030) & (K Units)
Table 85. Global POC Diagnostics Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 86. Alere Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 87. Alere POC Diagnostics Product Portfolios and Specifications
Table 88. Alere POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Alere Main Business
Table 90. Alere Latest Developments
Table 91. Roche Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 92. Roche POC Diagnostics Product Portfolios and Specifications
Table 93. Roche POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Roche Main Business
Table 95. Roche Latest Developments
Table 96. Abbott Laboratories Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 97. Abbott Laboratories POC Diagnostics Product Portfolios and Specifications
Table 98. Abbott Laboratories POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Abbott Laboratories Main Business
Table 100. Abbott Laboratories Latest Developments
Table 101. Johnson & Johnson Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson POC Diagnostics Product Portfolios and Specifications
Table 103. Johnson & Johnson POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Siemens Healthcare Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 107. Siemens Healthcare POC Diagnostics Product Portfolios and Specifications
Table 108. Siemens Healthcare POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Siemens Healthcare Main Business
Table 110. Siemens Healthcare Latest Developments
Table 111. Danaher Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 112. Danaher POC Diagnostics Product Portfolios and Specifications
Table 113. Danaher POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Danaher Main Business
Table 115. Danaher Latest Developments
Table 116. Bayer Healthcare Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 117. Bayer Healthcare POC Diagnostics Product Portfolios and Specifications
Table 118. Bayer Healthcare POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Bayer Healthcare Main Business
Table 120. Bayer Healthcare Latest Developments
Table 121. Beckman Coulter Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 122. Beckman Coulter POC Diagnostics Product Portfolios and Specifications
Table 123. Beckman Coulter POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Beckman Coulter Main Business
Table 125. Beckman Coulter Latest Developments
Table 126. Nipro Diagnostics Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 127. Nipro Diagnostics POC Diagnostics Product Portfolios and Specifications
Table 128. Nipro Diagnostics POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Nipro Diagnostics Main Business
Table 130. Nipro Diagnostics Latest Developments
Table 131. Bio-Rad Laboratories Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 132. Bio-Rad Laboratories POC Diagnostics Product Portfolios and Specifications
Table 133. Bio-Rad Laboratories POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Bio-Rad Laboratories Main Business
Table 135. Bio-Rad Laboratories Latest Developments
Table 136. Nova Biomedical Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 137. Nova Biomedical POC Diagnostics Product Portfolios and Specifications
Table 138. Nova Biomedical POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Nova Biomedical Main Business
Table 140. Nova Biomedical Latest Developments
Table 141. BioMerieux Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 142. BioMerieux POC Diagnostics Product Portfolios and Specifications
Table 143. BioMerieux POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. BioMerieux Main Business
Table 145. BioMerieux Latest Developments
Table 146. Quidel Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 147. Quidel POC Diagnostics Product Portfolios and Specifications
Table 148. Quidel POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Quidel Main Business
Table 150. Quidel Latest Developments
Table 151. Helena Laboratories Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 152. Helena Laboratories POC Diagnostics Product Portfolios and Specifications
Table 153. Helena Laboratories POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Helena Laboratories Main Business
Table 155. Helena Laboratories Latest Developments
Table 156. OraSure Technologies Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 157. OraSure Technologies POC Diagnostics Product Portfolios and Specifications
Table 158. OraSure Technologies POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. OraSure Technologies Main Business
Table 160. OraSure Technologies Latest Developments
Table 161. Accriva Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 162. Accriva POC Diagnostics Product Portfolios and Specifications
Table 163. Accriva POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Accriva Main Business
Table 165. Accriva Latest Developments
Table 166. Abaxis Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 167. Abaxis POC Diagnostics Product Portfolios and Specifications
Table 168. Abaxis POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Abaxis Main Business
Table 170. Abaxis Latest Developments
Table 171. Chembio Diagnostics Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 172. Chembio Diagnostics POC Diagnostics Product Portfolios and Specifications
Table 173. Chembio Diagnostics POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Chembio Diagnostics Main Business
Table 175. Chembio Diagnostics Latest Developments
Table 176. Trinity Biotech Basic Information, POC Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 177. Trinity Biotech POC Diagnostics Product Portfolios and Specifications
Table 178. Trinity Biotech POC Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Trinity Biotech Main Business
Table 180. Trinity Biotech Latest Developments
Related Reports
Allows one individual to access the purchased report Read More
Allows all employees of an organization to access the purchased report. Internal sharing only Read More
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (27 July, 2024)
- Notify To Team (27 July, 2024)
- Report updation (28 July, 2024)
- Report Quality Check (28 July, 2024)
- Report Dispatch (29 July, 2024)
- Hard Copy
Recently Viewed Products
Global POC Diagnostics Market Growth 2024-2030
We are friendly and approachable, give us a call.